共 51 条
- [1] Ahmed S., Mital A., Akhir A., Saxena D., Jahan K., Dubey G., Bharatam A., Dasgupta A., Chopra S., Jain R., Pyrrole-thiazolidin-4-one analogues exhibit promising anti-tuberculosis activity, Asian J Org Chem, 13, 6, (2024)
- [2] Akunuri R., Unnissa T., Kaul G., Akhir A., Saxena D., Wajidali M., Veerareddy V., Yaddanapudi V.M., Chopra S., Nanduri S., Synthesis and antibacterial evaluation of rhodanine and its related heterocyclic compounds against S. aureus and A. baumannii, Chem. Biodiversity, 19, (2022)
- [3] Alkhaibari I., Raj K.C.H., Angappulige D.H., Gilmore D., Alam M.A., Novel pyrazoles as potent growth inhibitors of staphylococci, enterococci and Acinetobacter baumannii bacteria, Future Med Chem, 14, 4, pp. 233-244, (2022)
- [4] Alkhzem A.H., Woodman T.J., Blagbrough I.S., Design and synthesis of hybrid compounds as novel drugs and medicines, RSC Adv, 12, 30, pp. 19470-19484, (2022)
- [5] Bourgard C., Rodriguez-Hernandez D., Rudenko A., Rutgersson C., Palm M., Larsson D.G.J., Farewell A., Grotli M., Sunnerhagen P., Development of dicationic bisguanidine-arylfuran derivatives as potent agents against Gram-negative bacteria, Antibiotics, 11, (2022)
- [6] Cotman A.E., Durcik M., Benedetto Tiz D., Fulgheri F., Secci D., Sterle M., Mozina S., Sterk G.J., Kikelj D., Discovery and hit-to-lead optimization of benzothiazole scaffold-based DNA gyrase inhibitors with potent activity against Acinetobacter baumannii and Pseudomonas aeruginosa, J Med Chem, 66, 2, pp. 1380-1425, (2023)
- [7] D'Atanasio N., Joannon A.C., Sante L.D., Mangano G., Ombrato R., Vitiello M., Bartella C., Magaro G., Prati F., Milanese C., Vignaroli C., Giorgio P.D., Tongiani S., Antibacterial activity of novel dual bacterial DNA type II topoisomerase inhibitors, PLoS ONE, 15, 2, (2020)
- [8] Delancey E., Allison D., Raj H.K.C., Gilmore D.F., Fite T., Basnakian A.G., Alam M.A., Synthesis of 4,4’-(4-formyl-1H-pyrazole-1,3-diyl) dibenzoic acid derivatives as narrow spectrum antibiotics for the potential treatment of Acinetobacter Baumannii infections, Antibiotics, 9, (2020)
- [9] Durcik M., Cotman A.E., Toplak Z., Mozina S., Skok Z., Szili P.E., Czikkely M., Tomasic T., Masic L.P., New dual inhibitors of bacterial topoisomerases with broad-spectrum antibacterial activity and in vivo efficacy against vancomycin-intermediate Staphylococcus aureus, J Med Chem, 66, 6, pp. 3968-3994, (2023)
- [10] El-Sayed S., Ahmed S.A., Gulia K., Lenhard J.R., Hassan A.H.E., Farahat A.A., Small molecules incorporating privileged amidine moiety as potential hits combating antibiotic-resistant bacteria, Pharmaceuticals, 16, (2023)